[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Icon Plc (ICLR)

Icon Plc (ICLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,988,606
  • Shares Outstanding, K 80,757
  • Annual Sales, $ 8,282 M
  • Annual Income, $ 791,470 K
  • EBIT $ 1,201 M
  • EBITDA $ 1,690 M
  • 60-Month Beta 1.23
  • Price/Sales 1.34
  • Price/Cash Flow 5.91
  • Price/Book 1.02

Options Overview Details

View History
  • Implied Volatility 53.72% (+2.17%)
  • Historical Volatility 72.68%
  • IV Percentile 63%
  • IV Rank 35.77%
  • IV High 90.64% on 04/24/26
  • IV Low 33.15% on 07/25/25
  • Expected Move (DTE 19) 12.07 (8.87%)
  • Put/Call Vol Ratio 0.19
  • Today's Volume 375
  • Volume Avg (30-Day) 914
  • Put/Call OI Ratio 1.61
  • Today's Open Interest 16,826
  • Open Int (30-Day) 12,194
  • Expected Range 124.00 to 148.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $2.80
  • Number of Estimates 3
  • High Estimate $3.10
  • Low Estimate $2.24
  • Prior Year $3.07
  • Growth Rate Est. (year over year) -8.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
108.80 +25.07%
on 05/04/26
139.69 -2.59%
on 05/28/26
+19.90 (+17.13%)
since 04/29/26
3-Month
95.75 +42.11%
on 03/19/26
139.69 -2.59%
on 05/28/26
+27.93 (+25.83%)
since 02/27/26
52-Week
66.57 +104.40%
on 02/12/26
211.00 -35.51%
on 07/24/25
+5.23 (+4.00%)
since 05/28/25

Most Recent Stories

More News
Icon Q4 Earnings Call Highlights

Icon (NASDAQ:ICLR) executives used the company’s latest earnings call to address the results of an accounting investigation, outline fourth-quarter and full-year 2025 performance, and provide guidance...

ICLR : 136.07 (-0.53%)
Icon PLC: Q4 Earnings Snapshot

Icon PLC: Q4 Earnings Snapshot

ICLR : 136.07 (-0.53%)
ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation

Highlights Quarter four revenue was $2,112.5 million. Full year revenue was $8,251 million. Quarter four adjusted...

ICLR : 136.07 (-0.53%)
ICON's First Post-Investigation Quarter Will Reveal Whether the Accounting Issues Were Truly Contained

Barchart Research What to Expect from ICLR Earnings ICLR Generated May 26, 2026 Current Price $113.85 EPS Estimate $$2.80 Consensus Rating Moderate Buy Average Move 9.83% ICON's First Post-Investigation...

ICLR : 136.07 (-0.53%)
ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that it will release financial results for the fourth quarter and full year 2025 results after the market...

ICLR : 136.07 (-0.53%)
Icon's Accounting Investigation Wraps Just in Time to Report Another Quarter of Declining Earnings

Barchart Research What to Expect from ICLR Earnings ICLR Generated May 19, 2026 Current Price $113.55 EPS Estimate $$2.80 Consensus Rating Moderate Buy Average Move 8.86% Icon's Accounting Investigation...

ICLR : 136.07 (-0.53%)
ICON expands US early phase research capabilities with new clinic and outpatient centres

New, 69.5K square-foot, state-of-the-art clinic in Texas integrates clinical, laboratory, and pharmacy infrastructure all under one roof Two new satellite outpatient clinics in Texas...

ICLR : 136.07 (-0.53%)
Icon's Delayed Earnings Will Reveal How Much Damage the Accounting Investigation Actually Caused

Barchart Research What to Expect from ICLR Earnings ICLR Generated May 12, 2026 Current Price $121.94 EPS Estimate $$2.80 Consensus Rating Moderate Buy Average Move 8.86% Icon's Delayed Earnings Will Reveal...

ICLR : 136.07 (-0.53%)
Icon Plc Reports Earnings After Three Months of Delayed Financials and Internal Review

Barchart Research What to Expect from ICLR Earnings ICLR Generated May 5, 2026 Current Price $121.32 EPS Estimate $$2.80 Consensus Rating Moderate Buy Average Move 8.86% Icon Plc Reports Earnings After...

ICLR : 136.07 (-0.53%)
ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company’s...

ICLR : 136.07 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 70%. The market has dropped from overbought territory. Beware of a potential mean reversion.

See More Share

Business Summary

ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

See More

Key Turning Points

3rd Resistance Point 146.16
2nd Resistance Point 142.31
1st Resistance Point 139.19
Last Price 136.07
1st Support Level 132.22
2nd Support Level 128.37
3rd Support Level 125.25

See More

52-Week High 211.00
Fibonacci 61.8% 155.83
Fibonacci 50% 138.78
Last Price 136.07
Fibonacci 38.2% 121.74
52-Week Low 66.57

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.